首页 | 本学科首页   官方微博 | 高级检索  
检索        

罗格列酮对人多囊肾囊肿衬里上皮细胞增殖的抑制作用
引用本文:刘春艳,梅长林,袁莉,张懿,付莉莉,蔡厚安.罗格列酮对人多囊肾囊肿衬里上皮细胞增殖的抑制作用[J].中华肾脏病杂志,2010,26(1):442-447.
作者姓名:刘春艳  梅长林  袁莉  张懿  付莉莉  蔡厚安
作者单位:大连医科大学附属二院肾内科;第二军医大学上海长征医院肾内科解放军肾脏病研究所,上海,200003;
摘    要:Objective To investigate the antiproliferative effect of rosiglitazone, a thiazolidinedione (TZD) on autosomal dominant polycystic kidney disease (ADPKD) cystic lining epithelial cells and to explore the underlying molecular mechanism. Methods ADPKD cysticlining immortalized epithelial (WT9-12) cells were stimulated by rosiglitazone with different concentrations. After treatment, MTT method was performed to detect the level of proliferation; flow cytometry was used to determine the cell cycle distribution and the apoptosis rate. Western blotting was used to detect the protein expressions of mTOR, p70S6K, 4E-Bp1, PPARγ PPARγ siRNA was transfected into WT9-12 cells to knock down the expression of PPARγ Results Treatment of WT9-12 cells with rosiglitazone resulted in a dose-dependent and time-dependent strong inhibition of cell proliferation, an accumulation of cells in the G0/G1 phase (rosiglitazone 50 μmol/L 65.43%,rosiglitazone 100 μmol/L 64.02%, control 49.65% ) and 6% apoptosis at high concentration (rosiglitazone 200 μmol/L). Rosiglitazone reduced the phosphorylation of p70S6K in a dosedependent and time-dependent manner. The levels of phosphorylated mTOR and 4E-Bp1, the latter being a downstream substrate of mTOR related mRNA translation initiation, were not changed by rosiglitazone. Cells were pre-incubated with GW9662, a PPARγ antagonist, before the treatment with rosiglitazone, the inhibition of p70S6 kinase phosphorylation by rosiglitazone was partially prevented by GW9662 (P<0.01). Then PPARγ siRNA was transfected into WT9-12 cells, in contrast to untransfected control or cells transfected with an irrelevant siRNA, rosiglitazone did not cause an obvious inhibition of p70S6 kinase phosphorylation in PPARγ knock-down.Conclusion Rosiglitazone inhibits the proliferation of ADPKD cystic lining epithelial cells, and down-regulates p70S6 kinase phosphorylation through mTOR-independent and PPARγ-dependent signal pathway.

关 键 词:多囊肾  常染色体显性    细胞周期    细胞凋亡    罗格列酮    哺乳类动物的雷帕霉素靶蛋白    

Antiproliferative effect of rosiglitazone on autosomal dominant polycystic kidney disease cystic lining epithelial cells
LIU Chun-yan,MEI Chang-lin,YUAN Li,ZHANG Yi,FU Li-li,CAI Hou-an.Antiproliferative effect of rosiglitazone on autosomal dominant polycystic kidney disease cystic lining epithelial cells[J].Chinese Journal of Nephrology,2010,26(1):442-447.
Authors:LIU Chun-yan  MEI Chang-lin  YUAN Li  ZHANG Yi  FU Li-li  CAI Hou-an
Abstract:
Keywords:p70S6KPolycystic kidney  autosomal dominantCell cycleApoptosisRosiglitazoneMammalian target of rapamycinp70S6K
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号